Massmutual Trust CO Fsb Fennec Pharmaceuticals Inc. Transaction History
Massmutual Trust CO Fsb
- $3.4 Billion
- Q1 2025
A detailed history of Massmutual Trust CO Fsb transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 982 shares of FENC stock, worth $8,641. This represents 0.0% of its overall portfolio holdings.
Number of Shares
982
Previous 982
-0.0%
Holding current value
$8,641
Previous $6,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding FENC
# of Institutions
70Shares Held
13.9MCall Options Held
10KPut Options Held
83.8K-
Southpoint Capital Advisors LP New York, NY4.08MShares$35.9 Million0.72% of portfolio
-
Sonic Gp LLC Honolulu, HI2.41MShares$21.2 Million33.54% of portfolio
-
Solas Capital Management, LLC Darien, CT2.25MShares$19.8 Million9.62% of portfolio
-
Black Rock Inc. New York, NY1.19MShares$10.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA965KShares$8.49 Million0.0% of portfolio
About FENNEC PHARMACEUTICALS INC.
- Ticker FENC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,067,300
- Market Cap $229M
- Description
- Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...